These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15019075)

  • 1. The use of inverse gas chromatography to assess the acid-base contributions to surface energies of cefditoren pivoxil and methacrylate copolymers and possible links to instability.
    Ohta M; Buckton G
    Int J Pharm; 2004 Mar; 272(1-2):121-8. PubMed ID: 15019075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities.
    Ohta M; Buckton G
    Int J Pharm; 2005 Jan; 289(1-2):31-8. PubMed ID: 15652196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the changes in surface energetics of cefditoren pivoxil as a consequence of processing induced disorder and equilibration to different relative humidities.
    Ohta M; Buckton G
    Int J Pharm; 2004 Jan; 269(1):81-8. PubMed ID: 14698579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives.
    Yokoi Y; Yonemochi E; Terada K
    Int J Pharm; 2004 Aug; 280(1-2):67-75. PubMed ID: 15265548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface Lewis acid-base properties of polymers measured by inverse gas chromatography.
    Shi B; Zhang Q; Jia L; Liu Y; Li B
    J Chromatogr A; 2007 May; 1149(2):390-3. PubMed ID: 17442325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
    Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
    Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water vapor adsorption properties of amorphous cefditoren pivoxil evaluated by adsorption isotherms and microcalorimetry.
    Ohta M; Tozuka Y; Oguchi T; Yamamoto K
    Drug Dev Ind Pharm; 2000 Jun; 26(6):643-9. PubMed ID: 10826112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic solvent-free approach to single step fabrication of Eudragit nanoparticles using Labrasol.
    Date AA; Jain A; Khachane P; Nagarsenker MS
    Pharmazie; 2010 Oct; 65(10):733-6. PubMed ID: 21105574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of surface heterogeneity of D-mannitol by sessile drop contact angle and finite concentration inverse gas chromatography.
    Ho R; Hinder SJ; Watts JF; Dilworth SE; Williams DR; Heng JY
    Int J Pharm; 2010 Mar; 387(1-2):79-86. PubMed ID: 20006691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers.
    Moustafine RI; Bukhovets AV; Sitenkov AY; Kemenova VA; Rombaut P; Van den Mooter G
    Mol Pharm; 2013 Jul; 10(7):2630-41. PubMed ID: 23777284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymethacrylate based microparticulates of insulin for oral delivery, part II: solid state characterization.
    Agarwal V; Khan MA; Nazzal S
    Pharmazie; 2008 Feb; 63(2):122-8. PubMed ID: 18380398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a powder containing an oily liquid drug with Eudragit EPO or L100 copolymer.
    Fujii M; Kawakami A; Saito A; Tuchiya H; Koizumi N; Watanabe Y
    Pharm Dev Technol; 2016 Dec; 21(8):1023-1028. PubMed ID: 26376360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the acid/base properties of MgY and NH4Y molecular sieves by inverse gas chromatography.
    Bilgiç C; Tümsek F
    J Chromatogr A; 2007 Aug; 1162(1):83-9. PubMed ID: 17451721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.